Abstract
Three cases of cerebrospinal fluid (CSF) leak, in subjects with an invasive macroprolactinoma under treatment with cabergoline (CAB), are reported. The patients underwent surgical treatment by means of an endoscopic endonasal transsphenoidal approach, which allowed removal of the lesion and sealing of the fistula. Many cases of CSF rhinorrhea are described in literature after bromocriptine therapy in invasive prolactinomas, but only one report has been recently published of such condition after CAB treatment. The complication is likely due to the brisk cessation of the so-called “stopper effect”, i.e. the tumor mechanically blocking the CSF leak in spite of its previous erosion of the skull-base, when CAB induces the macroprolactinoma shrinkage. Endoscopic transsphenoidal surgery offers a safe, minimally invasive and efficient management of this complication, which allows to regularly perform the following steps of the therapeutical strategy against the prolactinoma.
Similar content being viewed by others
References
Colao A., Annunziato L., Lombardi G. Treatment of prolactinomas. Ann. Med. 1998, 30: 452–459.
Webster J., Piscitelli G., Polli A., Ferrari C.I., Ismail I., Scanlon M.F. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 1994, 331: 904–909.
Molitch M.E. Medical treatment of prolactinomas. Endocrinol. Metab. Clin. North Am. 1999, 28: 143–169.
Colao A., Di Sarno A., Landi M.L., Cirillo S., Sarnacchiaro F., Facciolli G., Pivonello R., Cataldi M., Merola B., Annunziato L., Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J. Clin. Endocrinol. Metab. 1997, 82: 3574–3579.
Ferrari C.I., Abs R., Bevan J.S., Brabant G., Ciccarelli E., Motta T., Mucci M., Muratori M., Musatti L., Verbessem G., Scanlon M.F. Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin. Endocrinol. (Oxf.) 1997, 46: 409–413.
Carroll W.R., Cohen S., Sullivan M.J. Spontaneous CSF rhinorrhea: an unusual presentation of a pituitary adenoma. Otolaryngol. Head Neck Surg. 1991, 104: 380–383.
Obana W.G., Hodes J.E., Weinstein P.R., Wilson C.B. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenoma: report of two cases. Surg. Neurol. 1990, 33: 336–340.
Spaziante R., Corriero G., Cappabianca P., Russo A., Donzelli R., Irace C., Carrabs G. Rinoliquorrea rivelatrice di un adenoma ipofisario invasivo associato ad empty sella. Caso clinico. Quad. Med. Chir. 1987, 3: 1–6.
Aronoff S.L., Daughaday W.H., Laws E.R. Jr. Bromocriptine treatment of prolactinomas. N. Engl. J. Med. 1979, 300: 1391 (letter).
Barlas O., Bayindir C., Hepgul K., Can M., Kiris T., Sencer E., Unal F., Aral F. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surg. Neurol. 1994, 41: 486–489.
Baskin D.S., Wilson C.B. CSF rhinorrhea after bromocriptine for prolactinoma. N. Engl. J. Med. 1982, 306: 178.
Bronstein M.D., Musolino N.R., Benabou S., Marino R. Cerebropinal fluid rhinorrhea occurring in longterm bromocriptine treatment for macroprolactinomas. Surg. Neurol. 1989, 32: 346–349.
Hildebrandt G., Zierski J., Christophis P., Laun A., Schatz H., Lancranjan I., Klug N. Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta Neurochir. (Wien) 1989, 96: 107–113.
Holness R.O., Shlossberg A.H., Heffernan L.P. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma. Neurology 1984, 34: 111–113.
Pascal-Vigneron V., Weryha G., Braun M., Morel-Jean J., Bisset S., Leclère J. La rhinorrhée et l’otorrhée: des complications rares du traitement médical del prolactinomes invasifs. Ann. Endocrinol. (Paris) 1993, 54: 347–351.
Jho H.D., Carrau R. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J. Neurosurg. 1997, 87: 44–51.
Cappabianca P., Alfieri A., de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Min. Invas. Neurosurg. 1998, 41: 66–73.
Rothrock J.F., Laguna J.F., Reynolds A.F. Rhinorrhea from untreated pituitary adenoma. Arch. Neurol. 1982, 39: 442–443.
Nutkiewicz A., De Feo D.R., Kohut R.I., Fierstien S. Cerebrospinal fluid rhinorrhea as a presentation of pituitary adenoma. Neurosurgery 1980, 6: 195–197.
Spaziante R., de Divitiis E. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenomas. Surg. Neurol. 1991, 36: 150–151.
Leong K.S., Foy P.M., Swift A.C., Atkin S.L., Hadden D.R., MacFarlane I.A. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin. Endocrinol. (Oxf.) 2000, 52: 43–49.
Fager C.A. Nature and treatment of cerebrospinal fluid rhinorrhea in pituitary tumors. Surg. Clin. North Am. 1973, 53: 283–290.
Pellegrini I., Rasolonjanahary R., Gunz G., Bertrand P., Delivet S., Jedynak C.P., Kordon C., Peillon F., Jaquet P., Enjalbert A. Resistance to bromocriptine in prolactinomas. J. Clin. Endocrinol. Metab. 1989, 69: 500–509.
Ciccarelli E., Grottoli S., Razzore P., Gaia D., Bertagna A., Cirillo S., Cammarota T., Camanni M., Camanni F. Long-term treatment with cabergoline, a new longlasting ergoline derivative in idiopathic or tumorous hyperprolactinemia and outcome of drug-induced pregnancy. J. Endocrinol. Invest. 1997, 20: 547–551.
Colao A., Di Sarno A., Landi M.L., Scavuzzo F., Cappabianca P., Pivonello R., Volpe R., Di Salle F., Cirillo S., Annunziato L., Lombardi G. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pre-treated with other dopamine agonists: a prospective study in 110 patients. J. Clin. Endocrinol. Metab. 2000, 85: 2247–2252.
Colao A., Di Sarno A., Sarnacchiaro F., Ferone D., Di Renzo G., Merola B., Annunziato L., Lombardi G. Prolactinomas resistant to other dopamine agonists respond to chronic cabergoline treatment. J. Clin. Endocrinol. Metab. 1997, 83: 876–883.
Verhelst J., Abs R., Maiter D., van den Bruel A., Vandeweghe M., Velkeniers B., Mockel J., Lamberigts G., Petrossians P., Coremans P., Mahler C., Stevenaert A., Verlooy J., Raftopoulos C., Beckers A. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J. Clin. Endocrinol. Metab. 1999, 84: 2518–2522.
Kennedy D.W. Functional endoscopic sinus surgery. Technique. Arch. Otolaryngol. 1985, 111: 643–649.
Wigand M.E. Transnasal ethmoidectomy under endoscopic control. Rhinology 1981, 19: 7–15.
Cappabianca P., Alfireri A., Colao A., Ferone D., Lombardi G., de Divitiis E. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999, 9: 109–117.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cappabianca, P., Lodrini, S., Felisati, G. et al. Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases. J Endocrinol Invest 24, 183–187 (2001). https://doi.org/10.1007/BF03343840
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343840